Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
BackgroundGlioma is the most lethal and most aggressive brain cancer, and currently there is no effective treatment. Cancer immunotherapy is an advanced therapy by manipulating immune cells to attack cancer cells and it has been studied a lot in glioma treatment. Targeting the immune checkpoint CD47...
Main Authors: | Yu’e Liu, Shaojuan Lu, Yihong Sun, Fei Wang, Shibo Yu, Xi Chen, Lei-lei Wu, Hui Yang, Yufeng Shi, Kaijun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1166377/full |
Similar Items
-
QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment
by: Kaspar Bresser, et al.
Published: (2022-12-01) -
<i>QPCTL</i> Affects the Daily Weight Gain of the F2 Population and Regulates Myogenic Cell Proliferation and Differentiation in Chickens
by: Tuanhui Ren, et al.
Published: (2022-12-01) -
Functions of glutaminyl cyclase and its isoform in diseases
by: Liu Yu’e, et al.
Published: (2023-01-01) -
SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
by: Houshi Xu, et al.
Published: (2022-11-01) -
Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
by: Cong Luo, et al.
Published: (2021-11-01)